Rivista di formazione e aggiornamento professionale del pediatra e del medico di base, dal 1982 In collaborazione con l'Associazione Culturale Pediatri

Caso contributivo

PDF MeBrain

Dientamebiasi. Descrizione di un caso clinico in età pediatrica

Dientamebiasis. Description of a clinical paediatric case

Rocco Oliveto
Pediatra di famiglia, Padova

Giugno 2020 | DOI: 10.53126/MEBXXIIIG120

Abstract
Dientamoeba fragilis is a protozoan with an intestinal location and a cosmopolitan spread. Recent reports show its role in the appearance of intestinal syndromes (dientamebiasis). A clinical case of dientamebiasis is reported in a 7-year-old child suffering from cramp-like abdominal pain and diarrhoea with a protracted course and definitive resolution after a week’s treatment with paramomicin.
Contenuto riservato

Per leggere l'articolo è necessario effettuare il login.

Per l'acquisto del singolo articolo scrivi a abbonamenti@medicoebambino.com (la mail si prepara da sola con gli estremi dell'articolo); se accedi, la richiesta parte con un click.

Bibliografia

  1. Menéndez C, Fernández-Suarez J, Boga Ribeiro JA, et al. Epidemiological and clinical characteristics of Dientamoeba fragilis infection. Enferm Infect Microbiol Clin 2019;37(5):290-5. doi: 10.1016/j.eimc.2018.07.008.
  2. Pietilä JP, Meri T, Siikamäki H, et al. Dientamoeba fragilis - the most common intestinal protozoan in the metropolitan area of Helsinki, Finland 2007-2017. Euro Surveill 2019;24(29). doi: 10.2807/1560-7917.ES.2019.24.29.1800546.
  3. Barratt JL, Harkness J, Marriott D, Ellis JT, Stark D. The ambiguous life of Dientamoeba fragilis: the need to investigate current hypotheses on transmission. Parasitology 2011;138(5):557-72. doi: 10.1017/S0031182010001733.
  4. Burrows RB, Swerdlow MA. Enterobius vermicularis as a probable vector of Dientamoeba fragilis. Am J Trop Med Hyg 1956;5(2):258-65. doi: 10.4269/ajtmh.1956.5.258.
  5. Rostami A, Riahi SM, Haghighi A, Saber V, Armon B, Seyyedtabaei SJ. The role of Blastocystis sp. and Dientamoeba fragilis in irritabel bowel syndrome: a systematic rewiew and metanalysis. Int J Parasitol 2007;37(1):11-20. doi: 10.1007/s00436-017-5535-6.
  6. Windsor JJ, Bamber AI, Macfarlane L. Detection of Dientamoeba fragilis and Blastocystis hominis using a simple staining method. Br J Biomed Sci 2006;63(1):27-8. doi: 10.1080/09674845.2006.11978087.
  7. Stark D, Beebe N, Marriott D, Ellis J, Harkness J. Detection of Dientamoeba fragilis in fresh stool samples by PCR. Int J Parasitol 2005;35(1):57-62. doi: 10.1016/j.ijpara.2004.09.003.
  8. Stark D, Beebe N, Marriott D, Ellis J, Harkness J. Evaluation of three diagnostic methods, including real-time PCR, for detection of Dientamoeba fragilis in stool specimens. J Clin Microbiol 2006;44:232-5. doi: 10.1128/JCM.44.1.232-235.2006.
  9. Röser D, Simonsen J, Stensvold CR, et al. Metronidazole therapy for treating dientamoebiasis in children is not associated with better clinical outcomes: a randomized, double-blinded and placebo-controlled clinical trial. Clin Infect Dis 2014;58(12):1692-9. doi: 10.1093/cid/ciu188.
  10. van Hellemond JJ, Molhoek N, Koelewijn R, Wismans PJ, van Genderen PJ. Is paromomycin the drug of choice for eradication of Dientamoeba fragilis in adults? Int J Parasitol Drugs Drug Resist 2012;14(2):162-5. doi: 10.1016/j.ijpddr.2012.03.002.